Singapore markets closed
Straits Times Index
3,145.81 -5.75 (-0.18%) Nikkei
27,116.11 -195.19 (-0.71%) Hang Seng
17,740.05 -272.10 (-1.51%) FTSE 100
6,994.90 -2.37 (-0.03%) BTC-USD
19,605.33 -610.95 (-3.02%) CMC Crypto 200
446.19 -16.93 (-3.66%)
GILD Jan 2024 80.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:25PM EDT. Market open.
| Previous close | 2.0000 |
| Open | 2.2000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 80.00 |
| Expiry date | 2024-01-19 |
| Day's range | 2.0000 - 2.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 582 |
- Zacks
Gilead Sciences (GILD) Gains But Lags Market: What You Should Know
Gilead Sciences (GILD) closed at $62.32 in the latest trading session, marking a +1.02% move from the prior day.
- Business Wire
Kite Receives U.S. FDA Approval of Viral Vector Manufacturing Facility in Southern California to Produce Commercial Product
SANTA MONICA, Calif., October 03, 2022--Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved the company's retroviral vector (RVV) manufacturing facility in Oceanside, California, for commercial production. Viral vectors are key components needed to manufacture Kite’s cell therapies to treat certain blood cancers. Kite is the only cell therapy company with in-house commercial and clinical trial viral vector manufacturing capabilities, au
© 2022 Yahoo. All rights reserved.
